Development and Validation of Sibutramine Determination in Drug Products by Capillary Electrophoresis
Introduction. Recently, there has been a growing trend in the number of obese and overweight patients. To date, sibutramine is the most effective drug for treating obesity and overweight. The drug is an inhibitor of the reuptake of serotonin and norepinephrine, which leads to a decrease in hunger, a...
Main Authors: | A. M. Sukhanova, I. B. Perova, K. I. Eller, G. M. Rodionova, S. V. Chernova, V. N. Kuzina |
---|---|
Format: | Article |
Language: | Russian |
Published: |
LLC Center of Pharmaceutical Analytics (LLC «CPHA»)
2020-11-01
|
Series: | Разработка и регистрация лекарственных средств |
Subjects: | |
Online Access: | https://www.pharmjournal.ru/jour/article/view/851 |
Similar Items
-
DEVELOPMENT AND VALIDATION OF THE METHOD FOR DETERMINING THE QUANTITATIVE CONTENT 5-[2-(3-TRET-BUTYLAMINO-2-HYDROXYPROPOXY)PHENOXYMETHYL]-3-METHYL-1,2,4-OXADIAZOLEHYDROCHLORIDE IN OCULAR DRUG FILMS FOR THE TREATMENT OF OPEN-ANGLE GLAUCOMA
by: M. V. Bolshakova, et al.
Published: (2019-01-01) -
USE OF SIBUTRAMIN IN PHARMACEUTICAL DRUGS AND ANOREXIC DIETARY SUPPLEMENTS (REVIEW)
by: A. M. Sukhanova, et al.
Published: (2019-02-01) -
VALIDATION OF ANALYTICAL METHOD OF ASSAY OF SERPISTEN IN OINTMENT
by: E. I. Molokhova, et al.
Published: (2019-01-01) -
Development and Validation of Tadalafil Determination in Human Plasma by HPLC-MS Method
by: D. S. Bogdanova, et al.
Published: (2019-05-01) -
VALIDATION METHODS FOR QUANTITATIVE DETERMINATION OF 4,4'-DIMETHYL-7,7'-ETHYLENDIOXY-2H-1-DIBENZOPYRAN-2,2'-DIONE SUBSTANCE
by: C. B. Nguyen, et al.
Published: (2019-02-01)